Stock Price & Volume | Full Chart
No headlines found.
Adial Pharmaceuticals Engages The Keswick Group to Advance Partnering Activities for the Clinical Development of AD04 for Alcohol Use Disorder
Globe Newswire (Tue, 21-Mar 9:00 AM ET)
Adial Pharmaceuticals to Present at the 35th Annual Roth Conference on March 14th
Globe Newswire (Wed, 8-Mar 9:00 AM ET)
Adial Pharmaceuticals Provides Update on Regulatory Strategy for AD04 for Treatment of Alcohol Use Disorder
Globe Newswire (Mon, 6-Mar 4:19 PM ET)
Adial Pharmaceuticals Schedules Business Update Conference Call
Globe Newswire (Thu, 2-Mar 9:00 AM ET)
Adial Pharmaceuticals Announces Pricing of $0.75 Million At-The-Market Registered Direct Offering
Globe Newswire (Fri, 24-Feb 7:00 AM ET)
Adial Pharmaceuticals Confirms Scheduling of Meetings with FDA and European Regulatory Agencies to Advance Clinical Development of AD04 for Alcohol Use Disorder
Globe Newswire (Tue, 21-Feb 9:00 AM ET)
Adial Pharmaceuticals Enters Into Option Agreement for Sale of Purnovate Assets to Adenomed
Globe Newswire (Wed, 1-Feb 9:00 AM ET)
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.
Adial Pharmaceuticals - Warrant trades on the NASDAQ stock market under the symbol ADILW.
As of March 29, 2023, ADILW stock price was flat at $0.04 with 107 million shares trading.
ADILW has a market cap of $0.00. This is considered a Sub-Micro Cap stock.
In the last 3 years, ADILW stock traded as high as $2.45 and as low as $.01.
ADILW has underperformed the market in the last year with a price return of -92.3% while the SPY ETF lost -10.6%. However, in the short term, ADILW had mixed performance relative to the market. It has outperformed in the last 3 months, returning +100.5% vs +7.0% return in SPY. But in the last 2 weeks, ADILW shares have been beat by the market, returning -50.6% compared to an SPY return of +2.8%.
ADILW support price is $.02 and resistance is $.06 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ADILW stock will trade within this expected range on the day.